NYSE MKTHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NHC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage credit facilities to support acquisitions without overleveraging | Management is disciplined with capital, using credit to fund growth. | Intact | Credit usage exceeds $530 million without clear acquisition benefit | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
NHC is an acquisition-led healthcare growth story, with a sector tailwind and recent financial performance in the top half of its industry. The long-term thesis is intact, and the signal recently shifted from mixed to mildly favorable, but management execution is volatile and confidence in the evidence is medium.
Valuation is stretched, with NHC at a 1.2-times premium versus peers and an expectations gap of 0.19. The valuation evidence suggests expectations and the business outlook are aligned, while no fragility gates have fired.
Near-term revenue growth has been strong, rising 8.8% year over year in 2026-Q2, primarily from acquisitions; the $560 million acquisition of 35 NHI facilities closed in Q3. However, NHC has missed earnings in consecutive recent quarters, and the estimated chance of a miss is 46%, making the next report a key check on execution.
The multi-year thesis depends on NHC integrating acquisitions and expanding skilled nursing facility activity while managing the debt used to fund growth; capital allocation is rated behind plan. Near-term, a guidance cut or further weakness in job growth could weigh on the business outlook, while continued strong results and higher guidance from sector peers would support the sector backdrop.
Over the next 1 to 3 years, NHC’s growth case rests on acquisition execution and continued strong operating results, but the stretched valuation and recent earnings misses leave limited room for disappointment. The thesis remains intact, with the next guidance update and capital allocation progress as key checks. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in a supplied disclosure. Management reported: “We expect this transaction to be accretive to both earnings and cash flow, reinforcing our commitment to disciplined capital allocation and enhancing long-term shareholder value,” said Steve Flatt, Chief Executive Officer of NHC.” Operating income was $48.935 million in 2026-Q2.
Maintain quarterly dividends at or above $0.64 per share | They keep paying steady dividends of $0.64 per share. | Intact | Dividend per share falls below $0.64 in any quarter | Dividend per share: $0.67 per share FY2026-Q2; GAAP. Published target: >= $0.64 per share quarterly. Target period is not explicitly aligned with this observation. Aug 6, 20260.67 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: ““Continuing to provide exceptional patient care in these communities is a central priority, and acquiring this real estate ensures we have the operational control to achieve that objective.” Delivery assessment Nov 4, 2026 |
Expand M&A activity in skilled nursing facilities | National Healthcare grows by buying skilled nursing facilities. | Improving | Acquisition activity falls below $560 million in 2026-Q3 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: ““We are confident that owning these healthcare centers – versus leasing – will yield strong, long-term returns for our investors and is expected to be accretive to earnings and cash flow.” “We expect this transaction to be accretive to both earnings and cash flow, reinforcing our commitment to disciplined capital allocation and enhancing long-term shareholder value,” said Steve Flatt, Chief Executive Officer of NHC.” Revenue was $408.025 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.